- Home
- RLGT vs KMDA Comparison
RLGT vs KMDA Comparison
Compare RLGT & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLGT
- KMDA
- Stock Information
- Founded
- RLGT 2001
- KMDA 1990
- Country
- RLGT United States
- KMDA Israel
- Employees
- RLGT N/A
- KMDA N/A
- Industry
- RLGT Oil Refining/Marketing
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- RLGT Consumer Discretionary
- KMDA Health Care
- Exchange
- RLGT Nasdaq
- KMDA Nasdaq
- Market Cap
- RLGT 308.7M
- KMDA 310.1M
- IPO Year
- RLGT N/A
- KMDA N/A
- Fundamental
- Price
- RLGT $7.40
- KMDA $5.99
- Analyst Decision
- RLGT
- KMDA Strong Buy
- Analyst Count
- RLGT 0
- KMDA 2
- Target Price
- RLGT N/A
- KMDA $14.50
- AVG Volume (30 Days)
- RLGT 83.8K
- KMDA 40.9K
- Earning Date
- RLGT 11-12-2024
- KMDA 11-13-2024
- Dividend Yield
- RLGT N/A
- KMDA N/A
- EPS Growth
- RLGT N/A
- KMDA 230.67
- EPS
- RLGT 0.16
- KMDA 0.25
- Revenue
- RLGT $802,470,000.00
- KMDA $154,574,000.00
- Revenue This Year
- RLGT $10.44
- KMDA $14.85
- Revenue Next Year
- RLGT $6.41
- KMDA $7.64
- P/E Ratio
- RLGT $46.31
- KMDA $22.94
- Revenue Growth
- RLGT N/A
- KMDA 6.01
- 52 Week Low
- RLGT $4.83
- KMDA $4.58
- 52 Week High
- RLGT $7.54
- KMDA $6.53
- Technical
- Relative Strength Index (RSI)
- RLGT 71.55
- KMDA 77.16
- Support Level
- RLGT $6.57
- KMDA $5.84
- Resistance Level
- RLGT $6.89
- KMDA $6.06
- Average True Range (ATR)
- RLGT 0.18
- KMDA 0.12
- MACD
- RLGT 0.06
- KMDA 0.07
- Stochastic Oscillator
- RLGT 89.00
- KMDA 91.57
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.